Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Hepatitis B
2
Química clínica
2
Aspectos moleculares
1
Carcinogénesis química
1
Cáncer
1
Difteria
1
Enfermedades transmisibles
1
Epidemiología
1
Español
1
Hepatitis
1
Hepatitis A.
1
Hepatitis B.
1
Hepatitis C
1
Influenza
1
Inglés
1
Modelos matemáticos
1
Prevención y control
1
Tetanos
1
Tos Ferina
1
Tétanos
1
-
621por Luhadia, Kunjal, Abugrin, Mohamed, Kiani, Roudabeh, Ahmady, Abolfazl, Virk, Jaswinder, Yashi, Kanica“…In this study, we present the case of a patient who developed neurological symptoms immediately (one day) after receiving the hepatitis B vaccine. The temporality of symptoms makes us question whether there is an association between the hepatitis B vaccine and MS. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
622
-
623por Hudu, Shuaibu Abdullahi, Jimoh, Abdulgafar Olayiwola, Ibrahim, Kasimu Ghandi, Alshrari, Ahmed Subeh“…Moreover, only a small percentage of treated patients experience a functional cure with persistent hepatitis B surface antigen reduction. A significant proportion of deaths are caused by liver cirrhosis and hepatocellular cancer, which are both caused by chronic hepatitis B infection. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
624por Shrestha, A.B., Yadav, A.K., Shrestha, S., Shrestha, S.R., Shrestha, S., Yadav, H.R., Shrestha, S.“…Individuals with Silicosis are at high risk of developing Tuberculosis and Hepatitis B infection. Pulmonary function test, HRCT and Lung biopsies help in diagnosis of Silicosis. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
625
-
626por Sirilert, Sirinart, Khamrin, Pattara, Kumthip, Kattareeya, Malasao, Rungnapa, Maneekarn, Niwat, Tongsong, TheeraEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
627por Ishi, Kazuhisa, Suzuku, Fujihiko, Saito, Akira, Yoshimoto, Shinsaku, Kubota, Takeyoshi“…Objective: To investigate the prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV), and of hepatitis B surface (HBs) antigen in commercial sex workers (CSW) who attended a sexually transmitted disease (STD) clinic in Tokyo. …”
Publicado 2001
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
628Publicado 1993“…B and T cell responses of several strains of mice, immunized with a monoclonal antiidiotype (anti-Id) that mimics the a determinant of hepatitis B surface antigen (HBsAg), were studied to determine if the immune response to the anti-Id was regulated by H-2-linked immune response genes as has been previously observed for HBsAg. …”
Enlace del recurso
Enlace del recurso
Texto -
629“…BACKGROUND: Hepatitis B virus infection although preventable by vaccination remains an important health issue throughout the world due to its morbidity, mortality and economical losses. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
630por Yeh, Ming-Lun, Hung, Chao-Hung, Huang, Jee-Fu, Liu, Chun-Jen, Lee, Chuan-Mo, Dai, Chia-Yen, Wang, Jing-Houng, Lin, Zu-Yau, Lu, Sheng-Nan, Hu, Tsung-Hui, Yu, Ming-Lung, Kao, Jia-Horng, Chuang, Wan-Long, Chen, Pei-Jer, Chen, Ding-Shinn“…BACKGROUND: Interferon-α/ribavirin combination therapy might promote hepatitis B surface antigen (HBsAg) seroclearance in patients dually infected with hepatitis B and C viruses (HBV/HCV), but the long-term effect remains unclear. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
631por Kim, Hee Yeon, Choi, Jong Young, Park, Chung-Hwa, Song, Myeong Jun, Jang, Jeong Won, Chang, U Im, Bae, Si Hyun, Yoon, Seung Kew, Han, Joon Yeol, Kim, Dong Goo“…BACKGROUND/AIMS: The exclusion of hepatitis B core antibody (HBcAb)-positive donors from liver transplants (LTs) due to the risk of transmitting hepatitis B virus (HBV) does not appear to be practical in Korea, where hepatitis B is endemic. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
632por Afsharian, Mandana, Vaziri, Siavash, Janbakhsh, Ali Reza, Sayad, Babak, Mansouri, Feizollah, Nourbakhsh, Javad, Qadiri, Keyghobad, Najafi, Farid, Shirvanii, Maria“…BACKGROUND: Hepatitis B is the major cause of chronic hepatitis and cirrhosis in Iran. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
633“…BACKGROUND: Persistent hepatitis B virus (HBV) infection is a risk factor for hepatocellular carcinoma (HCC) development. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
634por Lin, Chih-Lang, Chien, Rong-Nan, Lin, Shi-Ming, Ke, Po-Yuan, Lin, Chen-Chun, Yeh, Chau-Ting“…Occult hepatitis B virus (HBV) infection is defined as persistence of HBV DNA in liver tissues, with or without detectability of HBV DNA in the serum, in individuals with negative serum HBV surface antigen (HBsAg). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
635“…BACKGROUND: Detection of hepatitis B virus (HBV) genomes without detectable hepatitis B surface antigen (HBs-Ag) is termed occult HBV infection (OHBV) that may be transmitted by blood transfusion or organ transplantation and has acute reactivation when an immunosuppressive status like human immunodeficiency virus (HIV) infection occurs. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
636por Tzeng, Horng-Tay, Tsai, Hwei-Fang, Chyuan, I-Tsu, Liao, Hsiu-Jung, Chen, Chun-Jen, Chen, Pei-Jer, Hsu, Ping-Ning“…Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
637por Liang, Ling-Bo, Zhu, Xia, Yan, Li-Bo, Du, Ling-Yao, Liu, Cong, Chen, Li-Yu, Liao, Juan, Tang, Hong“…OBJECTIVE: To explore the predictive value of serum hepatitis B surface antigen (HBsAg) titer and transient elastography in screening for insignificant fibrosis in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patients. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
638“…In this review, we focus on the Tregs and MDSCs that could be potential targets for immune therapy of chronic hepatitis B and HBV-related HCC.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
639“…After liver transplantation, the combination of long-term antiviral and low-dose hepatitis B Immune globulin (HBIG) can effectively prevent HBV recurrence in greater than 90% of transplant recipients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
640por Han, Jae Hyun, Kim, Dong Goo, Na, Gun Hyung, Kim, Eun Young, Lee, Soo Ho, Hong, Tae Ho, You, Young Kyoung, Choi, Jong Young, Yoon, Seung Kew“…PURPOSE: The use of hepatitis B core antibody (HBcAb)-positive grafts is increasing, especially where hepatitis B is endemic. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto